144 results
Page 3 of 8
8-K
EX-1.1
ccwzji vgkq
5 Aug 20
VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock
9:56pm
424B5
u3c0 tgwhg
3 Aug 20
Prospectus supplement for primary offering
8:45pm
424B5
j5y2xl 14uhtd
31 Jul 20
Prospectus supplement for primary offering
4:16pm
8-K
EX-10.1
tfat6s qwohjeo
26 Jun 20
Collaboration intended to support Phase 3 development and commercialization of PH94B in key Asian markets
5:27pm
424B3
dp6354p
15 May 20
Prospectus supplement
4:34pm
424B3
00fjcbm
15 Apr 20
Prospectus supplement
4:27pm
8-K
EX-10.1
rwt5a232
26 Mar 20
VistaGen Therapeutics Announces Common Stock Purchase Agreement for up to $10.25 Million
7:05am
8-K
EX-10.1
kwr92va g6
27 Jan 20
Entry into a Material Definitive Agreement
12:00am
S-8 POS
vdsp0q76g
1 Oct 19
Registration of securities for employees (post-effective amendment)
12:00am